Literature DB >> 4359409

Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.

T J Meyer, E E Ribi, I Azuma, B Zbar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4359409     DOI: 10.1093/jnci/52.1.103

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  22 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

2.  Effect of Mycobacterium bovis and Mycobacterium tuberculosis on the take and survival of chickens with transplanted MC-29 hepatoma.

Authors:  I Földes; A Gyuris
Journal:  Experientia       Date:  1975-07-15

3.  Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Adjuvant effect of cord factor, a mycobacterial lipid.

Authors:  R Saito; A Tanaka; K Sugiyama; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

5.  Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115.

Authors:  P H Phiet; J Wietzerbin; E Zissman; J F Petit; E Lederer
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.

Authors:  P Minden; P J Kelleher; J H Freed; L D Nielsen; P J Brennan; L McPheron; J K McClatchy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG.

Authors:  Z Reggiardo; A K Shamsuddin
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

8.  Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine. Demonstration of a defect in lymphoid cells.

Authors:  M Kakinuma; K Onoé; M Okada; T Kimura; K Kato; H Okuyama; K Morikawa; K Yamamoto
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

9.  A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy.

Authors:  H Yamagishi; H Ishibashi; M Kodama; T Tanaka; Y Harada; I Hashimoto
Journal:  Jpn J Surg       Date:  1982

10.  Antitumor effect of intrapleural administration of Lactobacillus casei in mice.

Authors:  T Matsuzaki; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.